The Readout Loud

View Top 200 Chart

Back to Rankings Page

Business
**The Readout Loud**

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Latest Episodes:

Episode 38: Your guide to the #CRISPRbabies controversy Nov 29, 2018

Show notes

What does it mean to edit a person? Has science run afoul of basic ethics? And what's the time difference to Hong Kong?

Episode 37: The biggest-ever IPO, drug prices rising in tandem, and burner Twitter accounts Nov 15, 2018

Show notes

Can unicorns float? Is a hot dog a sandwich? And how are drug companies like gas stations?

Episode 36: What the midterms mean, a golden age on hold, and the $4 million drug Nov 08, 2018

Show notes

Is pharma in for a swarm of subpoenas? Are we running out of ideas in oncology? And can a drug possibly be worth $4 million a dose?

Episode 35: Biotech's October slump, the precise cost of precision, and breaking postpartum silence Nov 01, 2018

Show notes

Why are biotech stocks in the dumps? Is the latest in cancer care overhyped? And what does "folie à deux" mean?

Episode 34: Pharma at the ballot box, the latest Alzheimer's argument, and a rare disease dilemma Oct 25, 2018

Show notes

Can pharma-shaming get someone re-elected? How rare is too rare when it comes to biotech research? And what does "positive" even mean, really?

Episode 33: Drug prices on TV, immortal blockbusters, and genetic privacy Oct 18, 2018

Show notes

Are prescription drugs like new cars? Is pharma's grand bargain a sham? And who keeps your DNA safe?

Episode 32: Fake friends at the FDA, cancer counter-narratives, and biotech's bear turn Oct 11, 2018

Show notes

Is the next big idea in oncology a bust? What does "successful" mean exactly? And why does Wall Street hate biotech all of a sudden?

Episode 31: Nobel snubs, millenial founders, and a new kind of lightning round Oct 04, 2018

Show notes

Did the Nobel Prizes go to the right scientists? Why is there so much disdain for biotech's millenial entrepreneurs? And do journalists have a good taste in '80s music?

Episode 30: A fish oil epiphany, VC monopolies and ketamine clinics Sep 27, 2018

Show notes

Was everyone wrong about fish oil? Is venture capital a cartel? And what's with all those ketamine clinics?

Episode 29: A Hong Kong heat-check, a $20 million wrist slap, and pharma's (other) diversity problem Sep 20, 2018

Show notes

Is a biotech bubble inflating in China? Do the feds coddle CEOs? And why don't clinical trials look like America?

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected